Shares of Catalyst Pharmaceuticals dropped 1.57% to $3.77 at 09:39 EST on Wednesday, after three consecutive sessions in a row of gains. The Nasdaq Stock Market is rising 1.25% to $12,595.10, after two consecutive sessions in a row of gains. This seems, at the moment, an all-around positive trend trading session today.
Catalyst Pharmaceuticals's last close was $3.83, 40.05% below its 52-week high of $5.28.
Catalyst Pharmaceuticals's Sales
Catalyst Pharmaceuticals's sales growth is 11.6% for the ongoing quarter and 4.6% for the next. The company's growth estimates for the ongoing quarter is 25% and a drop 10% for the next.
Catalyst Pharmaceuticals's Revenue
Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.
Catalyst Pharmaceuticals's Stock Top and Bottom Yearly Value
Catalyst Pharmaceuticals's stock is valued at $3.77 at 09:39 EST, way under its 52-week high of $5.28 and way higher than its 52-week low of $2.55.